surmount tirzepatide Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT-1 Study A Study of Tirzepatide (LY3298176)

How tirzepatide compares to other GLP-1 medications for non-weight-loss benefits Not all GLP-1 receptor agonists are created equal when it comes to benefits beyond the scale

GLP-1 RA initiation was defined as the first-ever recorded prescription of any GLP-1 RA agent in the Luxmed database during the study period

If you experience severe stomach pain, trouble swallowing, or signs of serious allergic reactions such as swelling or difficulty breathing, seek medical attention immediately

These habits deplete glutathione faster than tablets can restore it

GLP-1 is a naturally occurring hormone released in response to food intake